科济生物医药（上海）有限公司 CARSGEN THERAPEUTICS CO LTD
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
CARsgen Announces CAR T-cell Product Candidate CT041 Granted PRIME Eligibility by the EMA 2021-11-15 22:10
Appealing Data of CARsgen Therapeutics' CAR-T (CT041) in Advanced Gastric Cancer Presented at ESMO 2021-09-20 08:24
CARsgen Therapeutics officially listing on HKEX 2021-06-19 02:57
CARsgen Presents Preliminary Results of CAR-BCMA T Cell Therapy at ASH 2018 2018-12-04 20:00
CARsgen Therapeutics Completes $30 Million Series B Financing 2016-01-25 23:00
1